Gerard Drewes

Age UK — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

59h-index27.4kcitations176works12.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Microtubule and mitosis dynamics(46), Protein Degradation and Inhibitors(28), Alzheimer's disease research and treatments(22), Ubiquitin and proteasome pathways(17), Advanced Proteomics Techniques and Applications(14)

Publications176 total

Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens
Genome biology·2024· 12 citedOpen Access
Correction: Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
eLife·2023· 1 citedOpen Access
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Nature·2023Open Access
Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens
2023· 1 citedOpen Access
Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells
eLife·2023· 9 citedOpen Access
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Supplementary Methods from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S2 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S6 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Data from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S3 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S1 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S4 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
Figure S5 from Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Marcus Bantscheff(19), Eva‐Maria Mandelkow(15), Paola Grandi(9), Gérard Joberty(9), Bernhard Küster(8), Carsten Hopf(8), Dirk Eberhard(8), Eckhard Mandelkow�(8), Jacek Biernat(8), Anne‐Marie Michon(7), Tewis Bouwmeester(7), Gitte Neubauer(7), Rab K. Prinjha(7), Mikhail M. Savitski(7), Thilo Werner(7), Chun‐wa Chung(6), Mark A. Dawson(5), Antje Dittmann(5), Bernhard Trinczek(5), Andreas Bauer(4)